Icon Bioscience - About the company
Icon Bioscience is an acquired company based in Sunnyvale (United States), founded in 2004. It operates as an Online pharmacy providing prescription drugs and other health products. Icon Bioscience has raised $37.3M in funding. The company has 576 active competitors, including 25 funded and 30 that have exited. Its top competitors include companies like NimbleRx, Blink Health and Alto.
Company Details
Online pharmacy providing prescription drugs and other health products. It offers a wide selection of medications, including those for erectile dysfunction, birth control, asthma, and pain relief. The pharmacy sources products directly from manufacturers, emphasizing quality control and storage. Customers can transfer existing prescriptions or refill medications as guests. The platform also features a search function to easily locate specific products. Pharmacists are available to answer questions.
- Website
- iconbioscience.com/
Key Metrics
Founded Year
2004
Location
Sunnyvale, United States
Stage
Acquired
Total Funding
$37.3M in 3 rounds
Latest Funding Round
Investors
Ranked
46th among 576 active competitors
Employee Count
2 as on May 31, 2026
Exit Details
Acquired by pSivida (Mar 28, 2018)
Icon Bioscience's acquisition details
Click here to take a look at Icon Bioscience's acquisition in detail
Sign up to download Icon Bioscience's company profile
Icon Bioscience's funding and investors
Icon Bioscience has raised a total funding of $37.3M over 3 rounds. Its first funding round was on 2013. Icon Bioscience has 1 institutional investor.
Here is the list of recent funding rounds of Icon Bioscience:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 01, 2015 | 9940308 | Series B | 2325137 | 5531664 | 5487477 | 3671081 |
Aug 28, 2013 | 5099068 | Series B | 5439552 | 9710332 | 8326304 | 1961251 |
2013 | 8822 | Series A | 7594 | 6970 | 1638 | 9704 |
View details of Icon Bioscience's funding rounds and investors
Icon Bioscience's founders and board of directors
Founder? Claim ProfileIcon Bioscience's employee count trend
Icon Bioscience has 2 employees as of May 26. Here is Icon Bioscience's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Icon Bioscience's Competitors and alternates
Top competitors of Icon Bioscience include NimbleRx, Blink Health and Alto. Here is the list of Top 10 competitors of Icon Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | NimbleRx 2015, Palo Alto (United States), Acquired | Provider of digital pharmacy management software and prescription delivery services | $74.7M | 75/100 | |
2nd | Blink Health 2015, New York City (United States), Series B | Online pharmacy offering discounted prescription drugs | $165M | 75/100 | |
3rd | Alto 2015, San Francisco (United States), Acquired | Online pharmacy offering prescription delivery services | $592M | 75/100 | |
4th | Thirty Madison 2017, New York City (United States), Acquired | Healthcare platform offers various brands and personalized treatments | $210M | 66/100 | |
5th | Icebreaker Health 2014, San Francisco (United States), Acquired | Provider of remote patient consultation services and online delivery of medical care products | $64.7M | 66/100 | |
6th | Phil 2015, San Francisco (United States), Series D | Technology-driven hub simplifying medication access and improving patient outcomes | $100M | 64/100 | |
7th | PillPack 2013, Boston (United States), Acquired | Subscription based medicine ordering platform | $93.9M | 64/100 | |
8th | NowRx 2015, Mountain View (United States), Deadpooled | Online pharmacy for the delivery of medicines | $131M | 63/100 | |
9th | Capsule 2015, New York City (United States), Series D | Provider of an online pharmacy for delivering medicines | $570M | 62/100 | |
10th | Nurx 2015, San Francisco (United States), Series C | Online medication delivery company | $95.9M | 59/100 | |
46th | Icon Bioscience 2004, Sunnyvale (United States), Acquired | Online pharmacy providing prescription drugs and other health products | $37.3M | 35/100 |
Looking for more details on Icon Bioscience's competitors? Click here to see the top ones
Icon Bioscience's Investments and acquisitions
Icon Bioscience has made no investments or acquisitions yet.
Reports related to Icon Bioscience
Here is the latest report on Icon Bioscience's sector:
News related to Icon Bioscience
•
Global Retinoblastoma Drugs Market 2023 – Biolinerx, Glaxosmithkline, Cellceutix, Spectrum Pharmaceuticals, Baxter, Icon Bioscience, Rxi Pharmaceuticalsnewsfinancialanalyst.com•Feb 11, 2019•BioLineRx, GSK, Cellceutix, Spectrum Pharmaceuticals and 3 others
•
pSivida Acquires Icon BioscienceCitybizlist•Mar 28, 2018•Icon Bioscience, pSivida, SWK Holdings, EW Healthcare Partners and 2 others
•
•
•
Are you a Founder ?
FAQs about Icon Bioscience
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company